Skip to main content
Zanyu Technology Group Co., Ltd. logo

Zanyu Technology Group Co., Ltd. — Investor Relations & Filings

Ticker · 002637 ISIN · CNE1000019D4 LEI · 300300ZOPNYPT6RNH058 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,771 across all filing types
Latest filing 2025-09-01 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 002637

About Zanyu Technology Group Co., Ltd.

https://www.zanyu.com

Zanyu Technology Group Co., Ltd. specializes in the research, development, and manufacturing of surfactants and oleochemicals. The company's primary product portfolio includes anionic surfactants such as Sodium Lauryl Ether Sulfate (SLES/AES), Linear Alkylbenzene Sulfonate (LAS), and Alpha Olefin Sulfonate (AOS), alongside non-ionic surfactants and various specialty chemicals. Its oleochemical division focuses on the production of fatty acids, glycerin, and hydrogenated oils. These products serve as essential raw materials for the personal care, home care, and industrial cleaning sectors. Zanyu emphasizes technological innovation and large-scale production capabilities to provide high-quality chemical solutions. The company maintains a significant presence in the global chemical supply chain, leveraging its expertise in chemical engineering to support diverse applications in detergents, cosmetics, and food processing.

Recent filings

Filing Released Lang Actions
关于回购进展的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from a company about the progress of its share repurchase program. It details the number of shares repurchased, prices, total amount spent, compliance with regulatory rules, and the source of funds. It does not contain full financial statements or detailed financial analysis but rather updates on the status of a share buyback. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback activities.
2025-09-01 Chinese
半年度非经营性资金占用及其他关联资金往来情况汇总表
Regulatory Filings
2025-08-20 Chinese
关于董事会、监事会延期换届暨部分独立董事任期届满的提示性公告
Board/Management Information Classification · 95% confidence The document is an announcement from a company about the postponement of the board of directors and supervisory board re-election, as well as the expiration of terms for some independent directors. It discusses governance matters such as board continuity, independent director requirements, and election preparations. There is no financial data, no mention of financial results, no audit information, and no regulatory certifications. The content clearly relates to changes and updates in the company's board and management structure. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or a certification. Hence, the classification is MANG with high confidence.
2025-08-20 Chinese
2025年半年度报告
Regulatory Filings
2025-08-20 Chinese
2025年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2025 年半年度财务报告" which translates to "2025 Half-Year Financial Report". It contains detailed financial statements including consolidated balance sheets, profit and loss statements, cash flow statements, and changes in equity for the half-year period ending June 30, 2025. The document explicitly states it is a half-year report and includes comprehensive financial data and analysis, not just an announcement or summary. The length of the document (15,000 characters) and the presence of detailed financial tables confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-20 Chinese
关于2025年半年度计提资产减值准备及信用减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about the provision for asset impairment and credit impairment for the half-year period ending June 30, 2025. It details the amounts of impairment provisions made and explains the rationale and impact on financial results. The document is relatively short (1240 characters) and is a formal announcement of accounting estimates related to the half-year financial period. It does not contain full financial statements or comprehensive financial analysis typical of an Interim/Quarterly Report (IR). Instead, it is a regulatory announcement about impairment provisions, which is a specific financial update but not a full report. Given the nature and length, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories like IR or 10-K.
2025-08-20 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.